Zobrazeno 1 - 10
of 388
pro vyhledávání: '"Hidemi, Nakagawa"'
Autor:
Hidemi Nakagawa, Atsuyuki Igarashi, Hidehisa Saeki, Kenji Kabashima, Tomomi Tamaki, Hironobu Kaino, Yasushi Miwa
Publikováno v:
Allergology International, Vol 73, Iss 1, Pp 137-142 (2024)
Background: Delgocitinib ointment, a topical Janus kinase inhibitor, is used as treatment of patients with atopic dermatitis (AD) aged ≥2 years in Japan. Although initiating appropriate and early treatment upon the onset of AD in childhood is impor
Externí odkaz:
https://doaj.org/article/f79dccce14c14ebfb72a26a017344d36
Autor:
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G. Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 3, Pp 751-768 (2023)
Abstract Introduction Bimekizumab treatment resulted in improved clinical outcomes in patients with moderate-to-severe plaque psoriasis in BE VIVID, a 52-week, phase 3, randomized, ustekinumab and placebo-controlled study. We present data from the BE
Externí odkaz:
https://doaj.org/article/d03aa7955b37400c8563d4be5e6ba857
Autor:
Hironori Kawamoto, MD, Hiromichi Hara, MD, Shunsuke Minagawa, MD, Takanori Numata, MD, Jun Araya, MD, Yumi Kaneko, MD, Yoshinori Umezawa, MD, Akihiko Asahina, MD, Hidemi Nakagawa, MD, Kazuyoshi Kuwano, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 2, Iss 4, Pp 370-377 (2018)
Objective: To investigate the relationship between psoriasis and interstitial pneumonia (IP). Patients and Methods: We analyzed the clinical data of patients with psoriasis treated with biologic agents from June 1, 2008, to June 30, 2017, retrospecti
Externí odkaz:
https://doaj.org/article/b91dc6ce556042d38de85a93e084286f
Autor:
Hanae Miyagawa, Hiromichi Hara, Jun Araya, Shunsuke Minagawa, Takanori Numata, Yoshinori Umezawa, Akihiko Asahina, Hidemi Nakagawa, Kazuyoshi Kuwano
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245284 (2021)
ObjectivesAnti-IL-17/23 biologics are increasingly used to treat psoriasis. We aimed to elucidate characteristics of drug-induced interstitial pneumonia (DIIP) caused by anti-IL-17/23 biologics.MethodsWe retrospectively analyzed the clinical data of
Externí odkaz:
https://doaj.org/article/ce4cb10922864dc4bbbe3b746489e71b
Autor:
Hidemi Nakagawa, Chitoshi Kitamura
Publikováno v:
Acta Crystallographica Section E: Crystallographic Communications, Vol 73, Iss 12, Pp 1845-1849 (2017)
1-Hydroxy-4-propyloxy-9,10-anthraquinone, C17H14O4, (I), and its acetyl derivative, 4-acetyloxy-4-propyloxy-9,10-anthraquinone, C19H16O5, (II), were synthesized from the commercially available dye quinizarin. In both compounds, the anthraquinone fram
Externí odkaz:
https://doaj.org/article/d6a3764ec1fe4b34a87ed3f75078740b
Publikováno v:
Experimental Dermatology. 32:126-134
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78f2d02111d469d37f5c5fefe6bdb46b
https://doi.org/10.1111/exd.14686
https://doi.org/10.1111/exd.14686
Autor:
Norie Aizawa, Yozo Ishiuji, Mitsutoshi Tominaga, Sanae Sakata, Nobuaki Takahashi, Koichi Yanaba, Yoshinori Umezawa, Akihiko Asahina, Utako Kimura, Yasushi Suga, Kenji Takamori, Hidemi Nakagawa
Publikováno v:
Journal of Immunology Research, Vol 2019 (2019)
Background. Lipocalin-2 (LCN2), a protein secreted mainly by activated neutrophils, has been associated with neurodegeneration, obesity, and inflammatory responses. Serum LCN2 concentration has been reported elevated in patients with psoriasis, but l
Externí odkaz:
https://doaj.org/article/ed1fba1b89aa4af09631f565295dd5be
Autor:
Hidemi Nakagawa, Atsuyuki Igarashi, Hidehisa Saeki, Kenji Kabashima, Tomomi Tamaki, Hironobu Kaino, Yasushi Miwa
Publikováno v:
Allergology International.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f3916a61f25a2d0a85687c0c96a0b67
https://doi.org/10.1016/j.alit.2023.04.003
https://doi.org/10.1016/j.alit.2023.04.003
Publikováno v:
Stem Cell Research, Vol 17, Iss 1, Pp 32-35 (2016)
Expanded human T cells from a Japanese female with recessive dystrophic epidermolysis bullosa (RDBE) were used to generate integration-free induced pluripotent stem cells (iPSCs) by exogenous expression of four reprogramming factors, OCT3/4, SOX2, cM
Externí odkaz:
https://doaj.org/article/18d20fb586a247119c0406556fe6c76b
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 1, Pp 6-10 (2016)
Extramammary Paget's disease (EMPD) is an uncommon cutaneous adenocarcinoma arising from the apocrine glands within the epidermis or underlying skin appendages in the anogenital and axillary regions. Surgical excision is basically performed as a trea
Externí odkaz:
https://doaj.org/article/916015e0fe4b45f1aa4599489297e316